
Alpha-glycerophosphocholine (Alpha-GPC, or L-alpha-glycerylphosphorylcholine) is a highly bioavailable choline-containing compound used as a nootropic supplement and clinical treatment for cognitive decline. It is naturally found in the brain in small amounts and is produced endogenously through the degradation of phosphatidylcholine in cell membranes. Among available choline sources, Alpha-GPC is considered one of the most effective at raising brain choline levels, as it crosses the blood-brain barrier efficiently — a property that distinguishes it from simpler choline salts such as choline bitartrate.
Alpha-GPC supplies the essential nutrient choline, which the brain uses to synthesize acetylcholine, the primary neurotransmitter involved in memory, attention, and neuromuscular function. As a phospholipid precursor, it also contributes to membrane integrity and neuroplasticity. These dual roles — as an acetylcholine precursor and a structural membrane component — give Alpha-GPC a broader mechanistic profile than other choline sources. It is widely used both as a standalone supplement and as a complement to racetam nootropics, where cholinergic support is thought to prevent the headaches that some users experience when ACh demand is elevated without adequate supply.
In clinical settings, Alpha-GPC is approved in several European countries as a treatment for Alzheimer's disease and vascular dementia, where it has shown measurable improvements in cognitive function in controlled trials. Athletic use has also emerged, with evidence suggesting it may enhance growth hormone secretion and support power output when taken before exercise. Community experience generally mirrors the clinical literature: users describe subtle improvements in focus, verbal fluency, and memory recall, with some noting a "brain fog clearing" effect at doses of 300–600 mg. Excessive intake can cause excessive muscular tension, depression, and lethargy in choline-sensitive individuals — a pattern the community has identified as the "choline headache" or more broadly "choline overdose" syndrome.